Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daphne E Smith

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Diabetes Educator|March 26, 2009
Insulin pump therapy: guidelines for successful outcomesGary Scheiner, Robert J Sobel, Daphne E Smith, et al.
Diabetes, Obesity & Metabolism|July 5, 2018
Risk of amputations associated with SGLT2 inhibitors compared to DPP-4 inhibitors: A propensity-matched cohort studySruthi Adimadhyam, Todd A Lee, Gregory S Calip, et al.
British Journal of Clinical Pharmacology|October 9, 2018
Increased risk of mycotic infections associated with sodium-glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysisSruthi Adimadhyam, Glen T Schumock, Gregory S Calip, et al.
Pharmacoepidemiology and Drug Safety|October 25, 2019
Sodium-glucose co-transporter 2 inhibitors and the risk of fractures: A propensity score-matched cohort studySruthi Adimadhyam, Todd A Lee, Gregory S Calip, et al.
JAMA Network Open|September 29, 2023
Mobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical TrialBen S Gerber, Alana Biggers, Jessica J Tilton, et al.
The Annals of Pharmacotherapy|December 24, 2009
A pharmacist and health promoter team to improve medication adherence among Latinos with diabetesBen S Gerber, Alejandra I Cano, Maria L Caceres, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Diabetes Educator|March 26, 2009
Insulin pump therapy: guidelines for successful outcomesGary Scheiner, Robert J Sobel, Daphne E Smith, et al.
Diabetes, Obesity & Metabolism|July 5, 2018
Risk of amputations associated with SGLT2 inhibitors compared to DPP-4 inhibitors: A propensity-matched cohort studySruthi Adimadhyam, Todd A Lee, Gregory S Calip, et al.
British Journal of Clinical Pharmacology|October 9, 2018
Increased risk of mycotic infections associated with sodium-glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysisSruthi Adimadhyam, Glen T Schumock, Gregory S Calip, et al.
Pharmacoepidemiology and Drug Safety|October 25, 2019
Sodium-glucose co-transporter 2 inhibitors and the risk of fractures: A propensity score-matched cohort studySruthi Adimadhyam, Todd A Lee, Gregory S Calip, et al.
JAMA Network Open|September 29, 2023
Mobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical TrialBen S Gerber, Alana Biggers, Jessica J Tilton, et al.
The Annals of Pharmacotherapy|December 24, 2009
A pharmacist and health promoter team to improve medication adherence among Latinos with diabetesBen S Gerber, Alejandra I Cano, Maria L Caceres, et al.
Pageof 1